What is King Pharmaceuticals's all other lines — year 3?

King Pharmaceuticals (KG) reported all other lines — year 3 of 2.7% in Q4 2025.

What does all other lines — year 3 mean?

This represents the third year of development or maturity for claims within the 'All other lines' segment. It is a key data point for evaluating the stability of loss reserves and the accuracy of initial actuarial estimates as more claims are settled.

King Pharmaceuticals KG All other lines — Year 3

Other product segments

Commercial Auto Liability

18.7%—

General Liability

13.1%—

European Hospital Liability

10.4%—

International

2.7%—

Similar metrics at other companies

ACGLMulti-line and other specialty — Year Three

11%0.0pp

ACGLThird party claims-made business — Year Three

16.3%0.0pp

ACGLThird party occurrence business — Year Three

12.4%+0.1pp

GLREFinancial — Year 3

46.4%-4.4pp

GLREMultiline — Year 3

23%+3.4pp

SPNTProperty Other — Year 3

41.4%+12.0pp

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearThree.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's all other lines — year 3.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's all other lines — year 3?: King Pharmaceuticals (KG) reported all other lines — year 3 of 2.7% in Q4 2025.
What does all other lines — year 3 mean?: This represents the third year of development or maturity for claims within the 'All other lines' segment. It is a key data point for evaluating the stability of loss reserves and the accuracy of initial actuarial estimates as more claims are settled.